Global Medicines Program

January 24, 2014

Professor Andy Stergachis elected to prestigious Institute of Medicine

Professor Andy Stergachis, Director of the Global Medicines Program, was one of three faculty members from the University of Washington School of Public Health  elected to the prestigious Institute of Medicine, one of the highest honors in the fields of health and medicine.

The inductees are among 70 new members and 10 foreign associates announced Monday, Oct. 15, during the IOM’s 42nd annual meeting in Washington, D.C. The distinction recognizes outstanding professional achievement and commitment to service.

The School of Public Health inductees are:

  • Andy Stergachis, professor of Epidemiology, professor of Global Health, adjunct professor of Health Services, and adjunct professor in the Department of Pharmacy
  • Chris Elias, a clinical professor in the School’s Department of Global Health and president of global development for the Bill & Melinda Gates Foundation
  • Thomas Fleming, professor of Biostatistics and professor of Statistics

The Institute of Medicine, founded in 1970, is the health arm of the National Academy of Sciences and gathers experts to address issues from breast cancer and nutrition to patient safety and post-traumatic stress disorder. New members are elected by current members.

“I am extremely honored to be recognized by the IOM members,” said Stergachis, who holds a PhD in pharmacy administration from the University of Minnesota and a BPharm from Washington State University. “My first involvement with the Institute of Medicine was in 1995 when I served on their Committee to Study the Interactions of Drugs, Biologics, and Chemicals in Deployed U.S. Military Forces. Since then I have been fortunate to be called upon on several occasions to be of service to the IOM and see first-hand the lasting impact of its reports and other activities.”

Read more here